Cost-effectiveness analysis of pneumococcal conjugate vaccines, PCV21 vs PCV20, in adults aged ≥60 years in Germany.
- DOI
- 10.1080/14760584.2026.2739087
- Published
- 2026 Dec
- Container
- Expert review of vaccines
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1080/14760584.2026.2739087,
title = {Cost-effectiveness analysis of pneumococcal conjugate vaccines, PCV21 vs PCV20, in adults aged ≥60 years in Germany.},
author = {Simuzingili M and Mueller PP and Oexle LM and de Lepper M and Yi Z and Owusu-Edusei K},
year = {2026},
journal = {Expert review of vaccines},
doi = {10.1080/14760584.2026.2739087},
url = {https://doi.org/10.1080/14760584.2026.2739087}
}RIS
TY - JOUR TI - Cost-effectiveness analysis of pneumococcal conjugate vaccines, PCV21 vs PCV20, in adults aged ≥60 years in Germany. AU - Simuzingili M AU - Mueller PP AU - Oexle LM AU - de Lepper M AU - Yi Z AU - Owusu-Edusei K PY - 2026 JO - Expert review of vaccines DO - 10.1080/14760584.2026.2739087 UR - https://doi.org/10.1080/14760584.2026.2739087 ER -
APA
M, S., PP, M., LM, O., M, D. L., Z, Y., & K, O. (2026). Cost-effectiveness analysis of pneumococcal conjugate vaccines, PCV21 vs PCV20, in adults aged ≥60 years in Germany.. Expert review of vaccines. https://doi.org/10.1080/14760584.2026.2739087
Source records
- pubmed · retrieved 2026-11-10T14:29:17.744Z